the distributor of medical products said on Wednesday. January 29, 2025 Danaher misses quarterly profit estimates on weak biotech demand Danaher on Wednesday missed Wall Street estimates for ...

Vista Investment Partners, LLC, an investment management company, released the “Mar Vista U.S. Quality Strategy” fourth ...

With a market cap of $148.5 billion, Washington, the District Of Columbia-based Danaher Corporation (DHR) is a global ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Danaher Corporation (NYSE:DHR) manufactures and distributes a diverse portfolio of products and services for professional, medical, industrial, and commercial applications. The one-month return of ...

In this article, we are going to take a look at where Danaher Corporation (NYSE ... on improving drug quality and developing better products, necessitating the use of advanced equipment for ...

(RTTNews) - Danaher Corporation (DHR) said, for the first quarter 2025, the company anticipates that non-GAAP core revenue will decline low-single digits year-over-year. For full year 2025 ...

Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with ...

Shares of Danaher Corp. DHR rose 2.41% to $244.11 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.88% to 6,049.24 ...